Medicare Enrolled
Dr. Amritpal Anand, MD
Rheumatology · Elgin, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Anand from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anand?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Anand
Dr. Amritpal Anand is a rheumatology specialist in Elgin, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Anand performed 76,562 Medicare services across 940 unique beneficiaries.
Between the years covered by Open Payments, Dr. Anand received a total of $6,177 from 34 pharmaceutical and/or device companies across 289 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anand is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in IL
$6,177 industry payments
Medicare Practice Summary
Medicare Utilization ↗76,562
Medicare services
Top 13% in IL for rheumatology
940
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,030 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 49,400 | $5 | $25 |
| Romosozumab injection (Evenity) for osteoporosis | 14,130 | $8 | $40 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
9,250 | $10 | $73 |
| Denosumab injection (Prolia/Xgeva) | 1,560 | $19 | $91 |
| Gadobenate dimeglumine injection Administration of gadobenate dimeglumine, a contrast agent used to enhance imaging results. |
371 | $1 | $8 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
323 | $101 | $318 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
208 | $13 | $74 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
203 | $109 | $595 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
165 | $12 | $62 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
157 | $132 | $430 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
123 | $4 | $23 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
95 | $6 | $180 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
93 | $54 | $293 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
93 | $1 | $7 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
80 | $51 | $220 |
| New patient office visit, complex (60-74 min) | 64 | $178 | $958 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
63 | $54 | $220 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
55 | $57 | $210 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
53 | $45 | $203 |
| MRI of arm with and without contrast An MRI scan of the arm performed both before and after the administration of a contrast dye to enhance image detail. |
18 | $278 | $1,765 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $139 | $490 |
| MRI of arm without contrast An MRI scan of the arm that uses magnetic fields and radio waves to create detailed images of internal structures without the use of contrast dye. |
15 | $194 | $1,339 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
15 | $59 | $209 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
11 | $40 | $376 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.5% high complexity
86.4% medium
1.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,177
Total received (2018-2024)
Avg $882/year across 7 years
Top 27% in IL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
289
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,739 (92.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$419 (6.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$659
2023
$925
2022
$1,227
2021
$1,926
2020
$347
2019
$215
2018
$879
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$194
Janssen Biotech, Inc.
$128
ABBVIE INC.
$115
Amgen Inc.
$44
GlaxoSmithKline, LLC.
$33
Janssen Scientific Affairs, LLC
$30
UCB, Inc.
$27
Alexion Pharmaceuticals, Inc.
$26
PFIZER INC.
$25
Novartis Pharmaceuticals Corporation
$19
Lilly USA, LLC
$16
Top 3 companies account for 66.4% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$1,245
Amgen Inc.
$932
Janssen Biotech, Inc.
$626
ABBVIE INC.
$408
AstraZeneca Pharmaceuticals LP
$278
UCB, Inc.
$276
Pacira Therapeutics, Inc.
$266
AbbVie, Inc.
$259
PFIZER INC.
$174
Boehringer Ingelheim Pharmaceuticals, Inc.
$163
Novartis Pharmaceuticals Corporation
$161
Lilly USA, LLC
$155
GlaxoSmithKline, LLC.
$151
Horizon Therapeutics plc
$149
E.R. Squibb & Sons, L.L.C.
$100
Janssen Scientific Affairs, LLC
$95
Aurinia Pharma U.S., Inc.
$95
Mallinckrodt LLC
$81
GENZYME CORPORATION
$80
Celgene Corporation
$68
DePuy Synthes Sales Inc.
$60
SANOFI-AVENTIS U.S. LLC
$53
Genentech USA, Inc.
$53
Shire North American Group Inc
$45
Horizon Pharma plc
$32
Antares Pharma, Inc.
$30
Alexion Pharmaceuticals, Inc.
$26
Pacira Pharmaceuticals Incorporated
$21
Mylan Institutional Inc.
$18
ConvaTec Inc.
$17
Ethicon US, LLC
$17
Ferring Pharmaceuticals Inc.
$15
HERAEUS MEDICAL, LLC.
$13
KCI USA, Inc.
$12
Top 3 companies account for 45.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AQUACEL Ag Advantage Surgical · Actemra · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · HUMIRA · Hulio · Humira · ILARIS · Iovera · KEVZARA · KRYSTEXXA · LUPKYNIS · MONOVISC · OFEV · ORENCIA · ORTHOVISC · OTREXUP · PALACOS · PENNSAID · PREVENA · Prolia · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRATAFIX · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
59
Per 100K population
11.4
County median income
$100,678
Nearest hospital
ADVOCATE SHERMAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Anand is a mixed practice specialist, with above-average Medicare volume (top 13% in IL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Anand experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Anand performed 49,400 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anand receive payments from pharmaceutical companies?
Yes. Dr. Anand received a total of $6,177 from 34 companies across 289 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anand's costs compare to other rheumatologists in Elgin?
Dr. Anand's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anand) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Elgin
Browse rheumatologists in Elgin ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in IL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in IL
Which IL rheumatologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology